Medium materiality6/10
UBS raises Gilead price target to $195 after revenue beat and guidance increase
Why it may matterVerify against the original reporting
The target increase alongside the cited operating results and guidance is a bullish signal.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
UBS raised its GILD price target to $195. The headline cites a revenue beat and raised guidance; the posted price was $170.95.
- UBS raised its GILD target to $195.
- The headline cites a revenue beat and raised guidance.
- Posted price: $170.95.
Key facts
- 01
Target: $195
- 02
Posted price: $170.95
- 03
Analyst firm: UBS
- 04
Analyst: Michael Yee
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.